{
    "Trade/Device Name(s)": [
        "ARK Levetiracetam Assay",
        "ARK Levetiracetam Calibrator",
        "ARK Levetiracetam Control"
    ],
    "Submitter Information": "ARK Diagnostics, Inc.",
    "510(k) Number": "K091653",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083799"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "ORI",
        "LAS",
        "DLJ"
    ],
    "Summary Letter Date": "June 9, 2013",
    "Summary Letter Received Date": "October 21, 2009",
    "Submission Date": "October 20, 2009",
    "Regulation Number(s)": [
        "21 CFR 862.3350"
    ],
    "Regulation Name(s)": [
        "Diphenylhydantoin Test System"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "tdm"
    ],
    "Analyte(s)": [
        "Levetiracetam"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay (EIA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ARK Levetiracetam Assay, Calibrator, and Control for quantitative determination of levetiracetam in serum or plasma using homogeneous enzyme immunoassay.",
    "Indications for Use Summary": "Quantitative determination of levetiracetam in human serum or plasma on automated clinical chemistry analyzers to aid in management of patients treated with levetiracetam; calibrator and control are for use in calibration and quality control of the assay.",
    "fda_folder": "Toxicology"
}